AM3 inhibits LPS-induced iNOS expression in mice Journal Article


Authors: Majano, P.; Alonso-Lebrero, J. L.; Jańczyk, A.; Martín-Vichez, S.; Molina-Jiménez, F.; Brieva, A.; Pivel, J. P.; Gonzalez, S.; López-Cabrera, M.; Moreno-Otero, R.
Article Title: AM3 inhibits LPS-induced iNOS expression in mice
Abstract: We have analyzed the effect of a patented glycoconjugate of natural origin, AM3 (commercially available under the name Inmunoferon®) in the expression of iNOS induced by administration of LPS in mice. We have observed that oral treatment with the drug daily for 6 days reduced the levels of expression of iNOS induced by an intravenous pulse of LPS. This effect was significant in the lungs and kidneys, but it was much more marked in the liver. In addition, the levels of nitric oxide in serum were clearly decreased upon treatment with AM3. Together, these results suggest that AM3 modulates the nitric oxide response and points to a possible role for AM3 in the control of the inflammatory response. © 2005 Elsevier B.V. All rights reserved.
Keywords: controlled study; protein expression; drug efficacy; nonhuman; mouse; animals; mice; animal tissue; gene expression; animal experiment; animal model; inflammation; mice, inbred balb c; statistical significance; tumor necrosis factor-alpha; lipopolysaccharide; inhibition kinetics; rats; glycopeptides; kidney parenchyma; nitric oxide synthase; inducible nitric oxide synthase; nitric oxide synthase type ii; rats, inbred lew; nitric oxide; lung parenchyma; anti-inflammatory agents; lipopolysaccharides; calcium phosphates; inos; am3; anti-inflammatory response; inmunoferon; immunoferon; endotoxemia
Journal Title: International Immunopharmacology
Volume: 5
Issue: 7-8
ISSN: 1567-5769
Publisher: Elsevier Science, Inc.  
Date Published: 2005-07-01
Start Page: 1165
End Page: 1170
Language: English
DOI: 10.1016/j.intimp.2005.02.009
PUBMED: 15914321
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 7" - "Export Date: 24 October 2012" - "CODEN: IINMB" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Salvador Gonzalez Rodriguez
    203 Rodriguez